A new study reveals that a vaccine against a major cause of childhood illness and mortality in the world has sharply reduced the incidence of serious pneumococcal disease among Kenyan children since it was introduced in 2011.
The Johns Hopkins Bloomberg School of Public Health study reveals that after the vaccine against Streptococcus pneumoniae was introduced, the average annual incidence of serious pneumococcal disease dropped by 92 percent among children aged under five.
